相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Performance characteristics of a new Immulite® 2000 system erythropoietin assay
William E. Owen et al.
CLINICA CHIMICA ACTA (2011)
A novel monoclonal antibody immunoassay for the detection of human serum hepcidin
Peggy Schwarz et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Erythropoiesis Stimulatory Agent-Resistant Anemia in Dialysis Patients: Review of Causes and Management
Mehmet Kanbay et al.
BLOOD PURIFICATION (2010)
Signs of left heart volume overload in severely anaemic cats
Helen E. Wilson et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2010)
Dietary Intakes and Biochemical Status of B Vitamins in a Group of Children Receiving Dialysis
Tania Don et al.
JOURNAL OF RENAL NUTRITION (2010)
Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD
Wanja M. Bernhardt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Uremic Thrombocytopathy Is not about Urea
Gabor E. Linthorst et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Gastrointestinal disorders and renal failure: exploring the connection
Shayan Shirazian et al.
NATURE REVIEWS NEPHROLOGY (2010)
The Role of Hepcidin in Iron Metabolism
Elizabeta Nemeth et al.
ACTA HAEMATOLOGICA (2009)
Hepcidin for Clinicians
Brian Young et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Androgens and erythropoiesis: Past and present
S. Shahani et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2009)
Evaluation of Predictors of the Development of Azotemia in Cats
R. E. Jepson et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2009)
Influence of the level of renal insufficiency on endoscopic changes in the upper gastrointestinal tract
Radojica V. Stolic et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2008)
Novel erythropoiesis-stimulating agents: A new era in anemia management
Iain C. Macdougall
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Pure red cell aplasia induced by erythropoiesis-stimulating agents
Carol Pollock et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Raves and risks for erythropoietin
Kenneth Maiese et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Clinical use of a haemoglobin-based oxygen carrying solution (Oxyglobin®) in 48 cats (2002-2006)
Christiane Weingart et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2008)
Survival in cats with naturally occurring chronic kidney disease (2000-2002)
L. M. Boyd et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2008)
Aluminum Toxicity Following Administration of Aluminum-Based Phosphate Binders in 2 Dogs with Renal Failure
G. Segev et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2008)
Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients
Daniela Schiesser et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
The efficacy of intravenous darbepoetin alfa administered once every 2 weeks in chronic kidney disease patients on haemodialysis
Fernando Carrera et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Erythropoietin resistance in the treatment of the anemia of chronic renal failure
Anumeet Priyadarshi et al.
SEMINARS IN DIALYSIS (2006)
Relationship between serum carnitine, acylcarnitines, and renal function in patients with chronic renal disease
D Fouque et al.
JOURNAL OF RENAL NUTRITION (2006)
Managing erythropoietin hyporesponsiveness
C Kwack et al.
SEMINARS IN DIALYSIS (2006)
Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project
CL Bennett et al.
BLOOD (2005)
Antibody-mediated pure red cell aplasia (PRCA) treatment and re-treatment: multiple options
J Rossert et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risks
IC Macdougall
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Medical progress: Anemia of chronic disease
G Weiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Hematologic and biochemical abnormalities indicating iron deficiency are associated with decreased reticulocyte hemoglobin content (CHr) and reticulocyte volume (rMCV) in dogs
JD Steinberg et al.
VETERINARY CLINICAL PATHOLOGY (2005)
Molecular biology of erythropoietin
W Jelkmann
INTERNAL MEDICINE (2004)
Darbepoetin alfa effectively treats anemia in patients with chronic kidney disease with de novo every-other-week administration
RD Toto et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Platelet dysfunction in renal failure
P Boccardo et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2004)
Expression, bioactivity, and clinical assessment of recombinant feline erythropoietin
JF Randolph et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2004)
Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients
R Brunkhorst et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
E Nemeth et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Clinical application of a hemoglobin-based oxygen-carrying solution
MB Callan et al.
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2003)
Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin
JC Egrie et al.
EXPERIMENTAL HEMATOLOGY (2003)
Correction of anaemia with darbepoetin alfa in patients with chronic kidney disease receiving dialysis
IC Macdougall et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo)
F Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
The use of erythropoietin
CE Langston et al.
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2003)
Pathogenesis and treatment of anaemia of chronic disease
G Weiss
BLOOD REVIEWS (2002)
Darbepoetin alfa: A new therapeutic agent for renal anemia
IC Macdougall
KIDNEY INTERNATIONAL (2002)
The clinical impact of aluminium overload in renal failure
JB Cannata-Andia et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
The role of inflammation in the anaemia of end-stage renal disease
P Stenvinkel
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP)
IC Macdougall
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
Hepatotoxicity of stanozolol in cats
KR Harkin et al.
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2000)
分享论文
